Opioid control of the ruminant stomach motility: Functional importance of μ, κ and δ receptors

Abstract

In sheep, the subcutaneous (SC) or intracerebroventricular (ICV) administration of the μ-type opioid agonists, fentanyl and morphine, evokes a blockade of the cyclic contractions of the reticulum. A similar inhibition of forestomach motility was recorded following the administration of the two enkephalin analogs, DAla 2Met 5enkephalinamide (DAMA) and DAla 2DLeu 5enkephalin (DADLE) which are mixed μ - σ opioid agonists. In contrast, the reticular contractions were enhanced by the SC or ICV administration of the κ type agonist, ethylketazocine (EKC) and U - 50 488 H. The proximal duodenum motor activity was transiently increased resulting in the occurrence of a phase III-like activity by these opioid agonists, regardless of the subtypes. The effects of the opioid agonists on reticular motility were prevented by the injection of naloxone but not by the quaternary parent compound methylnaloxone which does not cross the blood-brain barrier. The duodenal motor effects elicited by the opioid agonists were antagonized by both naloxone and methylnaloxone. The results suggest that the inhibition of the ruminant stomach motility is centrally mediated by μ - δ type opioid agonists and are consistent with opposite effects from κ type opioid agonists. The stimulatory effect of peptide and non-peptide opioid agonists on the duodenum may result in part from direct opioid receptor-mediated actions on smooth muscle.